- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| AGAPE ATP Aktie jetzt für 0€ handeln | |||||
| 14.08. | Agape ATP Corp - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 20.07. | Agape ATP Corp - S-1/A, General form for registration of securities | 2 | SEC Filings | ||
| 16.07. | Agape ATP (ATPC) Stock Rallies Over 42% After Hours: Here's What Is Going On | 1 | Benzinga.com | ||
| 08.06. | Agape ATP Corp - S-1, General form for registration of securities | 3 | SEC Filings | ||
| 28.05. | Morning Market Movers: Intercont (Cayman), Agape ATP, Astrotech, Snowflake See Big Swings | 1.430 | AFX News | TOKYO (dpa-AFX) - At 8:05 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 15.05. | Agape ATP Corp - 10-Q, Quarterly Report | 4 | SEC Filings | ||
| 12.03. | Agape ATP Corporation Regains Compliance with Nasdaq Minimum Bid Price Requirement | 441 | ACCESS Newswire | KUALA LUMPUR, MY / ACCESS Newswire / March 12, 2026 / Agape ATP Corporation (NASDAQ:ATPC) ("ATPC" or "the Company") announced today that it has received confirmation from The Nasdaq Stock Market LLC... ► Artikel lesen | |
| 10.03. | AGAPE ATP Corporation Forges Strategic Collaboration with UAE-Based Citadel Investment | 1.061 | ACCESS Newswire | KUALA LUMPUR, MY / ACCESS Newswire / March 10, 2026 / NASDAQ-listed AGAPE ATP Corporation ("ATPC") through its subsidiary ATPC Green Energy Sdn. Bhd., has entered into a Collaboration Agreement with... ► Artikel lesen | |
| 06.02. | Agape ATP Corporation Announces 1-For-50 Reverse Stock Split | 653 | ACCESS Newswire | KUALA LUMPUR, MY / ACCESS Newswire / February 6, 2026 / Agape ATP Corporation (NASDAQ:ATPC) ("ATPC" or "the Company") announced that it intends to implement a 1-for-50 reverse stock split of its issued... ► Artikel lesen | |
| 05.02. | Agape ATP Corporation Receives Nasdaq Delisting Notice | 398 | ACCESS Newswire | KUALA LUMPUR, MY / ACCESS Newswire / February 5, 2026 / Agape ATP Corporation (NASDAQ:ATPC) ("ATPC" or "the Company") announced that it has received a notification from The Nasdaq Stock Market LLC ("Nasdaq")... ► Artikel lesen | |
| 29.01. | Agape ATP Corporation Receives Nasdaq Notice on Minimum Bid Price Requirement | 625 | ACCESS Newswire | KUALA LUMPUR, MY / ACCESS Newswire / January 29, 2026 / Agape ATP Corporation (NASDAQ:ATPC) ("ATPC" or "the Company") announced that it received a notification letter from the Listing Qualifications... ► Artikel lesen | |
| 12.12.25 | Agape ATP Corporation Issues Statement on Recent Market Activity and Reaffirms Strategic Outlook | 584 | ACCESS Newswire | KUALA LUMPUR, MY / ACCESS Newswire / December 12, 2025 / Agape ATP Corporation (NASDAQ:ATPC) ("ATPC" or "the Company") a provider of health and wellness products and sustainable energy solutions, today... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 7,920 | -1,17 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Legal Officer Transition | NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced a leadership transition in its legal function. After 11 years with... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,067 | 0,00 % | Sernova Biotherapeutics, Inc.: Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial | TORONTO and GERMANTOWN, Md., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO) and Seraxis Holdings, Inc. ("Seraxis") today announced... ► Artikel lesen | |
| CERENOME | 0,508 | -12,41 % | Cerenome names Ron Andrews as chief business officer | ||
| ATOSSA THERAPEUTICS | 1,950 | +1,04 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Nov. 10, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2027 Financial Results, Delivering First-ever Net Income Before Income Tax | Total revenue increased 28% for the quarter and 41% for the six months ended September 30, 2026 compared to same periods last yearU.S. revenue increased 93% for the quarter and 113% for the six months... ► Artikel lesen | |
| TANDEM DIABETES | 14,900 | -11,31 % | Tandem Diabetes Care names successor as CEO Sheridan retires | ||
| CO-DIAGNOSTICS | 0,289 | 0,00 % | Co-Diagnostics Reports Third Quarter 2026 Financial Results | Two Regulatory Submissions Under Review in India and the U.S. Third Quarter Operating Expenses Down 12% Year Over YearPlatform Capabilities Expanding with ReadyGo Collaboration, India Connectivity and... ► Artikel lesen | |
| QUIDELORTHO | 10,730 | +3,82 % | QuidelOrtho expects over $80M in 2027 annual savings as it narrows 2026 revenue to $2.52B-$2.54B | ||
| VERU | 2,140 | +0,94 % | Veru executive to present obesity drug data at industry conference | ||
| LIFEWARD | 5,840 | +0,52 % | Lifeward Ltd. - 8-K, Current Report | ||
| CLOVER HEALTH INVESTMENTS | 4,290 | -2,50 % | Clover Health auf der UBS Global Healthcare Conference: Starkes Wachstum trifft auf steigende Ertragskraft | ||
| SENSEONICS | 9,200 | +2,22 % | Senseonics delivers 'breakout quarter' more than doubling Eversense 365 revenue | ||
| TEMPEST THERAPEUTICS | 0,373 | 0,00 % | Tempest Therapeutics, Inc. - 8-K, Current Report | ||
| NANO-X IMAGING | 0,378 | +1,18 % | Nanox.AI signs distribution deal for cardiac imaging in Thailand | ||
| IMUNON | 0,780 | +13,04 % | IMUNON präsentiert translationale Daten aus Phase-2-Studie bei Eierstockkrebs |
AGAPE ATP CORPORATION gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 1,390 Euro und damit +2,96 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AGAPE ATP CORPORATION finden Sie auf Wallstreet Online.